A Deep Generative Model for the Inverse Design of Transition Metal Ligands and Complexes
JACS Au · 26.05.2025 · 5 (5) · 2294-2308
DOI: 10.1021/jacsau.5c00242 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACS Au, online erschienen am 23.04.2025. Verfasst von Magnus Strandgaard und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hylleraas Centre for Quantum Molecular Sciences, Department of Chemistry, University of Oslo, P.O. Box 1033, Blindern, Oslo 0315, Norway. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hylleraas Centre for Quantum Molecular Sciences, Department of Chemistry, University of Oslo, P.O. Box 1033, Blindern, Oslo 0315, Norway.
- Department of Chemistry, University of Copenhagen, Copenhagen 2100, Denmark.
- Centre for Materials Science and Nanotechnology, Department of Chemistry, University of Oslo, Oslo N-0315, Norway.
ORCID-Profile: Ainara Nova, Jan Halborg Jensen, David Balcells
Zitieren
APA
Strandgaard, M., Linjordet, T., Kneiding, H., Burnage, A. L., Nova, A., Jensen, J. H., & Balcells, D. (2025). A Deep Generative Model for the Inverse Design of Transition Metal Ligands and Complexes. JACS Au, 5(5), 2294-2308. https://doi.org/10.1021/jacsau.5c00242
Vancouver
Strandgaard M, Linjordet T, Kneiding H, Burnage AL, Nova A, Jensen JH, et al. A Deep Generative Model for the Inverse Design of Transition Metal Ligands and Complexes. JACS Au. 2025;5(5):2294-2308. doi:10.1021/jacsau.5c00242
BibTeX
@article{Strandgaard2025,
author = {Strandgaard, Magnus and Linjordet, Trond and Kneiding, Hannes and Burnage, Arron L and Nova, Ainara and Jensen, Jan Halborg and Balcells, David},
title = {A Deep Generative Model for the Inverse Design of Transition Metal Ligands and Complexes},
journal = {JACS Au},
year = {2025},
volume = {5},
number = {5},
pages = {2294--2308},
doi = {10.1021/jacsau.5c00242}
}
EUVIMED